SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-22-279779
Filing Date
2022-11-08
Accepted
2022-11-08 09:28:39
Documents
10

Document Format Files

Seq Description Document Type Size
1 F-3 d374528df3.htm F-3 440519
2 EX-4.6 d374528dex46.htm EX-4.6 308611
3 EX-4.7 d374528dex47.htm EX-4.7 322918
4 EX-5.1 d374528dex51.htm EX-5.1 72565
5 EX-5.2 d374528dex52.htm EX-5.2 14000
6 EX-23.1 d374528dex231.htm EX-23.1 1899
7 EX-FILING FEES d374528dexfilingfees.htm EX-FILING FEES 29654
8 GRAPHIC g374528dsp06.jpg GRAPHIC 9088
9 GRAPHIC g374528g00m03.jpg GRAPHIC 36701
10 GRAPHIC g374528g08a55.jpg GRAPHIC 101834
  Complete submission text file 0001193125-22-279779.txt   1385468
Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-268239 | Film No.: 221367505
SIC: 2836 Biological Products, (No Diagnostic Substances)